AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $876,000 | +72.4% | 64,512 | -3.7% | 0.04% | +48.3% |
| Q1 2020 | $508,000 | -11.3% | 66,991 | -26.1% | 0.03% | +31.8% |
| Q4 2019 | $573,000 | +57.4% | 90,634 | -2.3% | 0.02% | +46.7% |
| Q3 2019 | $364,000 | -19.1% | 92,794 | -0.2% | 0.02% | -16.7% |
| Q2 2019 | $450,000 | -41.1% | 93,012 | -0.3% | 0.02% | -41.9% |
| Q1 2019 | $764,000 | -31.0% | 93,282 | -39.5% | 0.03% | +34.8% |
| Q4 2018 | $1,108,000 | +62.5% | 154,250 | +99.8% | 0.02% | -11.5% |
| Q3 2018 | $682,000 | -11.7% | 77,190 | -0.2% | 0.03% | -18.8% |
| Q2 2018 | $772,000 | +47.9% | 77,310 | +41.2% | 0.03% | +45.5% |
| Q1 2018 | $522,000 | – | 54,741 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |